在患有慢性阻塞性肺病的日本患者中,四年死亡率和身体活动
Seiichi Kobayashi1, Fumi Chiba2, Masatsugu Ishida1
1Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital, 71 Nishimichishita, Hebita, Ishinomaki, 986-8522, Japan.
Respiratory investigation
|April 21, 2024
概括
身体活动显著降低了日本慢性阻塞性肺病 (COPD) 患者的死亡风险. 较高的活动水平与更好的长期存活相关,提供了积极的预后.
科学领域:
- 肺部医学 肺部医学
- 公共卫生 公共卫生
- 老年学是一门学科.
背景情况:
- 身体活动 (PA) 与慢性阻塞性肺病 (COPD) 患者的死亡风险有关.
- 现有的证据主要集中在非日本人口.
- 这项研究通过检查PA对日本COPD患者死亡率的影响来弥补这一差距.
研究的目的:
- 在日本一组慢性阻塞性肺病 (COPD) 患者中调查身体活动水平与长期死亡率之间的关联.
主要方法:
- 在日本的COPD患者身上进行了前性观察性研究.
- 死亡率在4年的随访期间进行了评估.
- 考克斯的比例危险模型被用来分析PA与死亡率的关系.
主要成果:
- 这项研究包括309名患者 (294名男性,平均年龄为76岁).
- 与低活动 (27.5%) 患者相比,高体力活动患者的全因死亡率 (4.1%) 显著降低.
- 调整后的危险比率证实,较高的体力活动与所有原因死亡率的降低有关.
结论:
- 较高的体力活动水平与日本慢性阻塞性肺病 (COPD) 患者的预后改善有关.
- 这些发现表明,促进身体活动可能有利于在不同患者群体中管理COPD结果.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


